CTSC:TTIC.021610 - Revision history

Valerie.humblet: /* Harvard Translational Imaging Consortium Meeting Minutes February 16, 2010 */

2010-02-19T21:31:47Z

Harvard Translational Imaging Consortium Meeting Minutes February 16, 2010

2010-02-19T21:31:31Z

Harvard Translational Imaging Consortium Meeting Minutes February 16, 2010

2010-02-19T21:31:09Z

2010-02-19T21:30:59Z

Harvard Translational Imaging Consortium Meeting Minutes February 16, 2010

2010-02-19T21:29:59Z

2010-02-19T21:18:43Z

Harvard Translational Imaging Consortium Meeting Minutes February 16, 2010

2010-02-19T21:15:26Z

2010-02-16T14:29:58Z

2010-02-16T04:45:22Z

2010-02-16T04:44:27Z

@@ Line 41: / Line 41: @@
 * Our imaging consortium received the following invitation on behalf of Dr Daniel Sullivan: I am writing to invite you to attend  a two-part workshop, “Coming to Consensus on Standards for Imaging Endpoints and Manufacturing of PET Radiopharmaceutical Products in Clinical Trials” to be held on April 13 and 14, 2010 at the Natcher Conference Center,  on the NIH campus in Bethesda, MD.  This two-day scientific workshop is being co-sponsored by the US Food and Drug Administration (FDA), SNM, and the Radiological Society of North America (RSNA) with key input from the National Cancer Institute’s Cancer Imaging Program.
-* Jeff plan to attend this meeting, we will discuss next week is other people should also attend.
+* Jeff plans to attend this meeting, we will discuss next week is other people should also attend.
 <br>

@@ Line 34: / Line 34: @@
 *At RSNA 2010, the RSNA is sponsoring the Quantitative Imaging Reading Room which debuted in 2009 as the Reading Room of the Future. The 2010 Quantitative Imaging Reading Room is an educational showcase for products and applications that integrate quantitative analysis and structured reporting into the image interpretation and reporting process. The quantitative imaging showcase will ring together various related efforts to provide visual and experiential exposure to the concepts of quantitative imaging and imaging biomarkers for RSNA attendees. For this purpose, quantitative imaging is defined as the extraction of quantifiable features from medical images. Completed proposals (no longer than 3 pages in length) must be submitted by April 1, 2010.
-** We will put this topics again on the agenda for next week when more people attend the t-con but it is a very good opportunity for our consortium.
+* We will put this topics again on the agenda for next week when more people attend the t-con but it is a very good opportunity for our consortium.
 <br>

@@ Line 8: / Line 8: @@
 # FDA,SNM, RSNA meeting April 13-14
 # Education program
 == Harvard Translational Imaging Consortium Meeting Minutes February 16, 2010 ==

← Older revision		Revision as of 21:30, 19 February 2010
Line 66:		Line 66:
	3/29: MGH lecture <br>		3/29: MGH lecture <br>
	5/21: BWH lecture <br>		5/21: BWH lecture <br>
		+	** Neuroimaging:
		+	2/23: Finalize speakers, lecture outline, learning objectives <br>
		+	3/2: Submit draft lectures <br>
		+	3/16: Finalize lecture <br>
		+	4/1: MGH lecture <br>
		+	4/9: BWH lecture <br>

@@ Line 8: / Line 8: @@
 # FDA,SNM, RSNA meeting April 13-14
 # Education program
 == Harvard Translational Imaging Consortium Meeting Minutes February 16, 2010 ==
@@ Line 48: / Line 43: @@
 <br>

← Older revision		Revision as of 21:18, 19 February 2010
Line 43:		Line 43:

	'''3. FDA,SNM, RSNA meeting April 13-14''' <br>		'''3. FDA,SNM, RSNA meeting April 13-14''' <br>
		+
		+	* Our imaging consortium received the following invitation on behalf of Dr Daniel Sullivan: I am writing to invite you to attend a two-part workshop, “Coming to Consensus on Standards for Imaging Endpoints and Manufacturing of PET Radiopharmaceutical Products in Clinical Trials” to be held on April 13 and 14, 2010 at the Natcher Conference Center, on the NIH campus in Bethesda, MD. This two-day scientific workshop is being co-sponsored by the US Food and Drug Administration (FDA), SNM, and the Radiological Society of North America (RSNA) with key input from the National Cancer Institute’s Cancer Imaging Program.
		+	* Jeff plan to attend this meeting, we will discuss next week is other people should also attend.
		+
		+	<br>

@@ Line 4: / Line 4: @@
 '''Agenda'''
-# Consultations: Imaging 129: Gordon Harris spoke with Brontes Technologies founders, Ed Tekeian and Jan Rohaly, through a contact from John Collins in CIMIT to discuss possible opportunities for their technology for skin surface 3D mapping, possibly to assist in evaluation of wound healing. I will help them connect with clinicians in wound healing for trauma and diabetes, as well as connect them with clinicians evaluating tracking growth and response of skin neurofibromas, to see if there is interest in collaboration. Does anyone have suggestions of who to talk with for wound healing (trauma and diabetes related)?
+# Consultations
 # Quantitative imaging reading room at RSNA 2010
 # FDA,SNM, RSNA meeting April 13-14
@@ Line 13: / Line 13: @@
 ##Date for registration
 ## Date for first draft of slides

← Older revision		Revision as of 04:45, 16 February 2010
Line 1:		Line 1:
		+	Back to [[Collaboration:Harvard_CTSC\|Collaboration:Harvard_CTSC]]
		+	<br>

	'''Agenda'''		'''Agenda'''

← Older revision		Revision as of 04:44, 16 February 2010
Line 1:		Line 1:
		+
		+	'''Agenda'''
		+
	# Consultations: Imaging 129: Gordon Harris spoke with Brontes Technologies founders, Ed Tekeian and Jan Rohaly, through a contact from John Collins in CIMIT to discuss possible opportunities for their technology for skin surface 3D mapping, possibly to assist in evaluation of wound healing. I will help them connect with clinicians in wound healing for trauma and diabetes, as well as connect them with clinicians evaluating tracking growth and response of skin neurofibromas, to see if there is interest in collaboration. Does anyone have suggestions of who to talk with for wound healing (trauma and diabetes related)?		# Consultations: Imaging 129: Gordon Harris spoke with Brontes Technologies founders, Ed Tekeian and Jan Rohaly, through a contact from John Collins in CIMIT to discuss possible opportunities for their technology for skin surface 3D mapping, possibly to assist in evaluation of wound healing. I will help them connect with clinicians in wound healing for trauma and diabetes, as well as connect them with clinicians evaluating tracking growth and response of skin neurofibromas, to see if there is interest in collaboration. Does anyone have suggestions of who to talk with for wound healing (trauma and diabetes related)?
	# Quantitative imaging reading room at RSNA 2010		# Quantitative imaging reading room at RSNA 2010